AMPED's logo.
Ticker Symbol: AMPED

Ampio Pharmaceuticals Inc

Exchange: OTC MARKETS Country: US Currency: USD Asset Type: Common Stock CIK:0001411906

Company Profile

Ampio Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company primarily engaged in the development of AmpionTM, its lead anti-inflammatory drug, which is currently undergoing clinical trials focused on the treatment of patients afflicted with COVID-19 induced acute respiratory distress syndrome (ARDS) as well as patients suffering from severe (KL-4) osteoarthritis of the knee (OAK). Both conditions impact a significant percentage of the population and due to the lack of any FDA approved drugs for treatment, there exists a significant unmet medical need. Ampion is backed by an extensive global patent portfolio with intellectual property protection extending through 2035. In addition, Ampion will be eligible for 12-year FDA market exclusivity upon approval as a novel biologic under the biologics price competition and innovation act (BPCIA).

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 373 Inverness Pkwy Ste 200
CEO: Michael Macaluso
Tags: N/A

Pricing

Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change: $0.11 ( 27.50%)
Days Range: $0.51 - $0.51
Beta: -
52wk. High: $0.57
52wk. Low: $0.01
Ytd. Change 2415.30%
50 Day Moving Average: $0.10
200 Day Moving Average: $0.10
Shares Outstanding: 226286867

Valuation

Market Cap: 11.5B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A